medigraphic.com
ISSN 0035-0052 (Impreso)

2004, Número 5

<< Anterior Siguiente >>

Rev Mex Pediatr 2004; 71 (5)


Neumonitis por Pneumocystis carinii. A propósito de un caso fatal

Carrada BT

Idioma: Español
Referencias bibliográficas: 49
Paginas: 229-236
Archivo PDF: 197.93 Kb.


RESUMEN

La incidencia de neumonía por Pneumocystis carinii en niños con VIH-SIDA ha motivado la investigación clínica y de laboratorio hacia este microorganismo, para el diagnóstico, tratamientos y prevención de la enfermedad que ocasiona. Se presenta el caso de un preescolar con esta enfermedad, la investigación clínico-patológica que dio lugar para identificar el P. carinii, las particularidades histopatológicas que caracterizan el daño que produce en los tejidos y la ultraestructura de este microorganismo. Se revisan los procedimientos de laboratorio disponibles para su diagnóstico y se destaca el desarrollo de anticuerpos monoclonales fluorescentes y la reacción en cadena de polimerasa. También se hace mención a la quimioterapia, con la combinación trimetoprim-sulfametoxazol (TMP-SMZ) y otras alternativas terapéuticas, y a las medidas de prevención.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Walzer PD. Pneumocystis carinii. In: Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 5a Ed. Filadelfia: Churchill-Livingstone, 2000: 2781-95.

  2. Stringer JR, Walzer PD. Molecular biology and epidemiology of Pneumocystis carinii infection in AIDS. AIDS 1996; 10: 561-71.

  3. Tasci S, Ewing S, Burghard A, Lüderitz B. Pneumocystis carinii pneumonia. Lancet 2003; 362: 124-5.

  4. Arean VM. Pulmonary Pneumocystosis. In: Marcial-Rojas RA. Pathology of Protozoal and Helminthic Diseases. Baltimore: Williams & Wilkins, 1971.

  5. Campbell WG. Ultrastructure of Pneumocystis in human lung. Arch Pathol 1972; 93: 312-21.

  6. Morris A, Ben Beard C, Huang L. Update on the epidemiology and transmission of Pneumocystis carinii. Microb Infect 2002; 4: 95-103.

  7. Ruskin J, Remington JS. Neumocistosis. En: Hoeprich PD. Tratado de Enfermedades Infecciosas. Barcelona: Salvat 1982: 410-15.

  8. Walzer PD, Schultz MG, Western K, Robbins JB. Pneumocystis carinii pneumonia and primary immune deficiency disease of infancy and childhood. J Pediatr 1973; 82: 416-22.

  9. Hughes WT. Pneumocystis carinii Pneumonia. In: Pediatrics AIDS the Challenge of HIV infection in Infants, Children and Adolescents. Baltimore: Williams & Willkins, 1994: 405-18.

  10. Ognibene FP, Gil VJ, Pizzo PA. Induced sputum to diagnose Pneumocystis carinii pneumonia in immunosuppresed pediatric patients. J Pediatr 1989; 115: 430-3.

  11. Frenkel JK. Pneumocystosis. In: Binford ChH, Connor D. Pathology of Tropical and Extraordinary Diseases. Vol I. Washington DC: Armed Forces Inst Pathology 1976: 303-7.

  12. Cregan P, Yamamoto A, Lum A. Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens. J Clin Microbiol 1990; 28: 2432-6.

  13. Aslanzadeh J, Stelmach PS. Detection of Pneumocystis carinii with direct fluorescence antibody and calcofluor white stain. Infection 1996; 24: 248-50.

  14. Kitada K, Oka S, Kimwa S, Shimada K, Serikawa T. Detection of Pneumocystis carinii sequence by polymerase chain reaction: Animal models and clinical applications to noninvasive specimens. J Clin Microbiol 1992; 29: 1985-90.

  15. Kasolo F, Lshimpi K, Chintu Ch, Mwaba P, Mudenda V, Maswabu D et al. Identification of Pneumocystis carinii DNA by polymerase chain reaction in necropsy lung samples from children dying of respiratory illnesses. J Pediatrics 2002; 140: 367-9.

  16. Ridaura-Sanz C. Infección por Pneumocystis carinii en niños. Características anatomoclínicas de 23 casos de autopsia. Patología 1995; 33: S7-S12.

  17. Bye MR, Bernstein L, Shah K, Ellawie M, Rubinstein A. Diagnostic bronchoalveolar lavage in children with AIDS. Pediatr Pulmonol 1987; 3: 425-8.

  18. Kovaks JA, Gill VJ, Masur H. New Insights Into Transmission, Diagnosis and Drug Treatment of Pneumocystis carinii Pneumonia. JAMA 2001; 286: 2450-60.

  19. Cushion MT. Transmission and epidemiology. In: Walzer PD ed. Pneumocystis carinii Pneumonia New York, NY: Marcel-Dekker, 1994: 122-39.

  20. Jesserum J, Angeles-Angeles A, Gasman N. Comparative demographic and autopsy findings in the acquired immune deficiency syndrome in two Mexican populations. J Acquir Immune Defic Syndrome 1990; 3: 579-83.

  21. Hughes WT, Price RA, Kim HK, Coburn TP, Grisby D, Feldman S. Pneumocystis carinii pneumonitis in children with malignancies. J Pediatr 1973; 82: 404-415.

  22. Vanek J, Jirovek O. Parasitare Pneumonie “Interstitielle” Plasma Zellen Pneumoniae del Fruhgeborenen, verursacht durch Pneumocystis carinii. Zentral bl Bakteriol (Orig A). 1952; 158: 120-127.

  23. Gajdusek DC. Pneumocystis carinii- etiologic agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics 1957; 19: 543-65.

  24. Hughes WT. Pneumocystis carinii pneumonitis. Boca Raton, Fl: CRC Press, 1987.

  25. Rogers MA. AIDS in children: a review of the clinical, epidemiological and public health aspects. Pediatr Infect Dis 1985; 4: 230-36.

  26. Kaplan JE, Hanson D, Dworkin MS. Epidemiology of human immunodeficiency virus –associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30(Suppl 1): S5-S14.

  27. Pifer LL, Hughes WT, Stagno S, Woods D. Pneumocystis carinii infection: Evidence of high prevalence in normal and immunosuppressed children. Pediatrics 1978; 61: 35-40.

  28. Meuwissen JHE, Tauber Th, Leeuwenberg ADEM, Beckers PJA, Sieben M. Parasitology and serologic observations of infection with Pneumocystis carinii in humans. J Infect Dis 1977; 136: 43-48.

  29. Figueroa-Medrano LP, Xochihua-Díaz L, Figueroa-Damián R. Características clínicas y epidemiológicas de pacientes pediátricos con infección VIH/SIDA: informe de 124 pacientes. Bol Med Hosp. Infant Mex 2001; 58; 771-9.

  30. Maldonado JS, Gutierrez-Rojas A, Conde-Mercado JM, Estrada-Aguilera A. La evolución de pacientes con SIDA en el Hospital Juárez de México. Med Inter Mex 2000; 16: 111-6.

  31. del Río-Chiribonga C, Tellez-Gómez I, Orzechowski-Rallo A, Alanis-Ortega A. The Spectrum of HIV Infection in Patients Seen at a Private Hospital in Mexico City: 115 Patients Seen from 1984 to 1999. Arch Med Res 1996; 27: 201-4.

  32. Gómez-Campos G, Villareal-Urenda C, Robles-Romo M, Cano-Domínguez C. Hallazgos histopatológicos en 102 autopsias de pacientes con Síndrome de Inmunodeficiencia Adquirida. Rev Med IMSS (Mex) 1992; 30: 171-6.

  33. Centers for Disease Control and Prevention. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1989; 38: 1-9.

  34. Volpe F, Ballantine SP, Delves CI. The multifunctional folic acid synthesis fas gene of Pneumocystis carinii encodes dihydroneopterin aldolase, hidroxymethsintethase. Eur J Biochem 1993; 216: 449-58.

  35. Centers for Disease Control and Prevention, 1999. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1999; 48: 1-66.

  36. Para MF, Finkelstein D, Becker S. Reduced toxicity with gradual initiation of trimethoprim for Pneumocystis carinii pneumonia: AIDS clinical trial group 268. J Acquir Immune Defic Syndr Hum Retrovirol 2000; 24: 337-43.

  37. Ioannidis JP, Cappelleni JC, Skolnik PR. A metanalysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. Arch Intern Med 1996; 156: 177-88.

  38. Looareesuwan S, Viravan C, Webster HK. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 1996; 54: 62-6.

  39. Walker DJ, Wakenfield AE, Dohn MN. Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure. J Infect Dis 1998; 178: 1767-1775.

  40. Bozzette SA, Sattler FR, Chiu J. A controlled field trial adjunctive treatment with corticoesteroides for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990; 323: 1451-7.

  41. Simonds RJ, Hughes WT, Feinberg J, Navin TR. Preventing Pneumocystis carinii Pneumonia in Persons Infected with Human Immunodeficiency Virus. Clin Infect Dis 1995; 21(Suppl 1): S44-S48.

  42. López-Bernaldo de Quiroz JC, Miro JM, Peña JM, Podzamczer D, Alberdi JC, Martinez E et al. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV-infection. N Engl J Med 2001; 344: 159-67.

  43. Edman JC, Kovacs JA, Masur H, Santi DV, Elwood HJ, Sogin ML. Ribosomal RNA sequence shows Pneumocystis carinii to be member of the fungi. Nature 1988; 334: 519-29.

  44. Hughes TT. Pneumocystis carinii: Taxing the taxonomy. Eur J Epidemiol 1989; 17: 5349-58.

  45. Fishmand JA. Pneumocystis carinii pneumonia. In: Fishman AP ed. Update: Pulmonary diseases and disorders. New York: McGraw-Hill, 1992. 263-86.

  46. Fishman JA, Lee MJ, Mattia AR. Case 3-1995, Records of the Massachussets General Hospital. N Engl J Med 1995; 332: 249-57.

  47. Telzak EE, Cote RJ, Gold JWM, Campbell SW, Armstrong D. Extrapulmonary Pneumocystis carinii infection. Rev Infect Dis 1990; 12: 380-386.

  48. Afessa B, Green W, Chiao J. Pulmonary complications of HIV-infections: autopsy findings. Chest 1998; 113: 1225-29.

  49. Ruviglioni MC. Extrapulmonary pneumocystosis. The first 50 cases. Rev Infect Dis 1990; 12: 1127-38.




2020     |     www.medigraphic.com